Related Experiment Video
Updated: May 26, 2026

09:44
A High-throughput, High-content, Liquid-based C. elegans Pathosystem
Published on: July 1, 2018
Target-based and whole-worm screening approaches to anthelmintic discovery
1CSIRO Livestock Industries, 306 Carmody Rd, St Lucia, QLD 4067, Australia. andrew.kotze@csiro.au
Veterinary Parasitology
|December 14, 2011
Summary
Discovering new anthelmintics involves target-based and whole-worm screening. This study explores nematode intestine and external layers as drug targets, illustrating methods for identifying novel anthelmintic agents.
Area of Science:
- Parasitology
- Drug Discovery
- Molecular Biology
Background:
- Anthelmintic drug discovery relies on target-based and whole-worm screening.
- Nematode intestine and external layers are key potential drug targets.
- Understanding drug modes of action is crucial for developing new treatments.
Purpose of the Study:
- To review experimental approaches for identifying novel anthelmintics.
- To highlight the significance of nematode intestine and external layers as drug targets.
- To exemplify target-based drug discovery using the ecdysone signaling pathway.
Main Methods:
- Review of target-based screening assays and in silico drug design.
- Utilizing whole-worm assays to identify anthelmintic agents.
- Analysis of recent literature on nematode ecdysone signaling pathway receptors.
Main Results:
- Disruption of nematode intestine and external layers by specific anthelmintics demonstrates their potential as drug targets.
- Whole-worm screening identified anthelmintic activity in agents with known insect activity.
- Ecdysone signaling pathway receptors in nematodes offer a model for target-based screening.
Conclusions:
- Both target-based and whole-worm screening are valuable for anthelmintic discovery.
- Targeting nematode-specific structures like the intestine and external layers is a promising strategy.
- Further research into specific molecular targets can advance high-throughput drug screening.
Related Concept Videos
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

